Cytodyn Inc (CYDY)

[Learning53]

Limited perspective - Yes, cash is nice and given time the "flood gates" will open. Though Currently, it appears "others" (including academic institutions) are seeing the gold at the end of the rainbow and looking to "cash in" by doing their own research utilizing the amazing drug, Leronlimab.

It won't be long before some insightful BP entity will embrace the same procedure and look for ways Leronlimab would be a helpful adjuvant for their drugs - potentially increasing effectiveness and helping to minimize negative side effects. If it has to do with CCR5 it's worth exploring with Leronlimab!

So the first approvals of Leronlimab MAY NOT be so far away after all.

Just my opinion, but "the game already appears to be afoot."

:) GLTAL